SK
Sharon Kedar
OtherActiveCo-Founder, Partner at Northpond Ventures
34
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sharon Kedar.
Investment Thesis & Strategy
Sharon Kedar, as a Partner at Northpond Ventures, invests in various stages of biotech companies, focusing on those with innovative technologies and the potential for significant impact.
Investment Activity
Deals per year over the last 3 years
6
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 34 companies
H
Hawthorne Effect
Healthcare · Seed, 0
T
Teckro
Healthcare · Series B, 0
D
DNAnexus
Biotech · Series B, 0
9
908 Devices
Biotech · Series B, 0
F
Farcast
Biotech · Seed, 2021
A
Artisan Bio
Biotech · Seed, 2020
S
Sherlock Biosciences
Biotech · Series B, 2019
V
Vigil Neuroscience
Biotech · Series A, 2019
D
Delfi Diagnostics
Biotech · Series B, 2019
G
General Automation Lab Technologies
Biotech · Seed, 2019
V
Vizgen
Other · , 2019
E
Encodia
Biotech · Series B, 2019
Frequently Asked Questions
Sharon Kedar focuses on Seed stage investments.